Prophase Labs (PRPH) 1.40 $PRPH
ProPhase Labs reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:48AM CST
PRPH: 1.40 (+0.01)
ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2014
Marketwired - Thu Nov 13, 7:31AM CST
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $5.1 million for the three months ended September 30, 2014 as compared to net sales of $5.9 for the three months ended September 30, 2013. During the three months ended September 30, 2014, the Company recorded a $3.6 million non-cash charge to operations ("Impairment Charge"
for the impairment of its intangible asset, licensed technology related to its Phusion Labs joint venture. The Company realized a net loss, inclusive of the Impairment Charge, for the three months ended September 30, 2014, of $3.2 million, or ($0.18) per share, compared to net income of $1.2 million, or $0.08 per share, for the three months ended September 30, 2013.
PRPH: 1.40 (+0.01)
ProPhase anticipates USD3.6m impairment charge in the Q3 fiscal 2014
M2 - Thu Sep 11, 7:51AM CDT
Medical science company ProPhase Labs (NASDAQ
RPH) said on Wednesday that it expects to report a USD3.6m charge for the impairment of its intangible asset, certain licensed technology related to its Phusion Laboratories joint venture during the third quarter of fiscal 2014.
PRPH: 1.40 (+0.01)
ProPhase Expects to Report a $3.6 Million Impairment Charge Relating to Its Phusion Joint Venture
Marketwire - Wed Sep 10, 3:16PM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) announced today it will likely report a $3.6 million charge for the impairment of the Company's intangible asset, certain licensed technology, related to its Phusion Laboratories, LLC ("Phusion" joint venture during the third quarter of fiscal 2014.
PRPH: 1.40 (+0.01)
ProPhase Finalizes Resolution of Long-Standing Litigations
Marketwire - Wed Sep 10, 3:10PM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) announced today the Company has consummated a definitive, global Settlement Agreement ("Settlement Agreement" resolving all of its litigation with certain of the Company's former managers and with certain shareholders. The cases that have been settled include ProPhase Labs, Inc. v. Quigley, et al., Court of Common Pleas of Bucks County, Pennsylvania, Civ. A. No. 2010-08227; ProPhase Labs, Inc. v. Quigley, et al., Court of Common Pleas of Bucks County, Pennsylvania, Civ. A. No. 2011-09815; the appeal filed by the plaintiff in the matter Quigley v. ProPhase Labs. Inc.'s Officers and Directors, el al, Court of Common Pleas of Philadelphia County, December Term, 2011, No. 111200409; together with certain ancillary litigation.
PRPH: 1.40 (+0.01)
ProPhase Labs posts higher net loss of USD3.1m for three months ended 30 June 2014
M2 - Wed Aug 13, 7:52AM CDT
Medical science company ProPhase Labs (NASDAQ RPH) disclosed on Tuesday its net loss of USD3.1m (USD0.19 per share) for the three months ended 30 June 2014.
PRPH: 1.40 (+0.01)
ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2014
Marketwire - Tue Aug 12, 7:02AM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $1.8 million for the three months ended June 30, 2014 as compared to net sales of $1.9 million for the three months ended June 30, 2013. The Company realized a net loss for the three months ended June 30, 2014, of $3.1 million, or ($0.19) per share, compared to a net loss of $1.7 million, or ($0.11) per share, for the three months ended June 30, 2013.
PRPH: 1.40 (+0.01)
Nasdaq stocks posting largest volume increases
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
RIVR: 21.48 (+0.48), PRPH: 1.40 (+0.01), VRTX: 112.72 (-3.96), CENT: 7.90 (-0.06), NURO: 1.67 (+0.06), PLXT: 6.50 (+0.02), PRKR: 1.10 (+0.02), CENTA: 8.59 (-0.04), COCO: 0.16 (unch), MSBF: 8.51 (+0.06), UCBA: 12.04 (+0.04), MCRS: 67.99 (unch), NSPH: 0.43 (-0.01)
4 Stocks Under $10 Moving Higher
at The Street - Fri Mar 28, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
PRPH: 1.40 (+0.01), BXE: 4.55 (-0.26), FHCO: 4.31 (-0.10), OSUR: 8.96 (-0.22)
ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2013
Marketwire - Thu Mar 27, 9:12AM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported a net sales increase of 5.8% to $9.6 million for the three months ended December 31, 2013 as compared to net sales of $9.1 million for the three months ended December 31, 2012.
PRPH: 1.40 (+0.01)
OTC Daily Alert Stock Watch - ProPhase Labs, Inc. (NASDAQ: PRPH)
WorldStockWire - Mon Sep 02, 5:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
PRPH: 1.40 (+0.01)
ProPhase Labs Reports Financial Results for the First Quarter Ended March 31, 2013
Marketwire - Mon May 06, 8:30AM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported a net sales increase of 25.3% to $7.5 million for the three months ended March 31, 2013 as compared to net sales of $6.0 million for the three months ended March 31, 2012.
PRPH: 1.40 (+0.01)
ProPhase Labs Inc's net loss narrows to USD1.1m in 2012
M2 - Wed Mar 27, 9:15AM CDT
Medical science company ProPhase Labs Inc (NASDAQ RPH) stated on Tuesday its net loss of USD1.1m (USD0.07 per share) for the year ended 31 December 2012.
PRPH: 1.40 (+0.01)
Market Maker Surveillance Report. CBMX, CBB, AMBO, PRPH, XWES, EORBF, Losing Stocks With Lowest Price Friction For Wednesday, February 27th 2013
M2 - Thu Feb 28, 2:49AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3942 companies with "abnormal" market making, 3560 companies with positive Friction Factors and 1802 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Wednesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. CombiMatrix Corp (NASDAQ:CBMX), Cincinnati Bell Inc (NYSE:CBB), Ambow Education Holding Ltd (NYSE:AMBO), Prophase Labs Inc (NASDAQ RPH), World Energy Solutions Inc (NASDAQ:XWES), (OTC:EORBF). To access Friction Factor, Naked Short Data and SqueezeTrigger Price
PRPH: 1.40 (+0.01), XWES: 5.45 (unch), CBMX: 1.37 (-0.07), CBB: 3.41 (-0.03)
Market Maker Surveillance Report. PTSX, NVTL, PRPH, RNIN, MNOV, CWH, Winning Stocks With Lowest Price Friction For Tuesday, February 26th 2013
M2 - Wed Feb 27, 2:38AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4094 companies with "abnormal" market making, 2796 companies with positive Friction Factors and 2447 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Point.360 (NASDAQ TSX), Novatel Wireless Inc (NASDAQ:NVTL), Prophase Labs Inc (NASDAQ RPH), Wireless Ronin Technologies Inc (NASDAQ:RNIN), MediciNova Inc (NASDAQ:MNOV), CommonWealth REIT (NYSE:CWH). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices
PTSX: 0.32 (+0.01), PRPH: 1.40 (+0.01), MNOV: 3.04 (-0.01), CWH: 26.86 (-0.33), NVTL: 2.56 (+0.02)
Matrixx Initiatives Withdraws Acquisition Offer for ProPhase Labs
PR Newswire - Tue Feb 05, 8:00AM CST
Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, announced today that it has withdrawn the $1.60 per share offer it made in October to acquire all of the outstanding shares of ProPhase Labs, Inc. (NASDAQ: PRPH) .
PRPH: 1.40 (+0.01)
ProPhase Labs reports Q3 earnings
Seeking Alpha - at Seeking Alpha - Thu Nov 13, 9:48AM CST
PRPH: 1.40 (+0.01)
ProPhase Labs Reports Financial Results for the Three and Nine Months Ended September 30, 2014
Marketwired - Thu Nov 13, 7:31AM CST
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $5.1 million for the three months ended September 30, 2014 as compared to net sales of $5.9 for the three months ended September 30, 2013. During the three months ended September 30, 2014, the Company recorded a $3.6 million non-cash charge to operations ("Impairment Charge"
for the impairment of its intangible asset, licensed technology related to its Phusion Labs joint venture. The Company realized a net loss, inclusive of the Impairment Charge, for the three months ended September 30, 2014, of $3.2 million, or ($0.18) per share, compared to net income of $1.2 million, or $0.08 per share, for the three months ended September 30, 2013. PRPH: 1.40 (+0.01)
ProPhase anticipates USD3.6m impairment charge in the Q3 fiscal 2014
M2 - Thu Sep 11, 7:51AM CDT
Medical science company ProPhase Labs (NASDAQ
RPH) said on Wednesday that it expects to report a USD3.6m charge for the impairment of its intangible asset, certain licensed technology related to its Phusion Laboratories joint venture during the third quarter of fiscal 2014. PRPH: 1.40 (+0.01)
ProPhase Expects to Report a $3.6 Million Impairment Charge Relating to Its Phusion Joint Venture
Marketwire - Wed Sep 10, 3:16PM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) announced today it will likely report a $3.6 million charge for the impairment of the Company's intangible asset, certain licensed technology, related to its Phusion Laboratories, LLC ("Phusion"
joint venture during the third quarter of fiscal 2014. PRPH: 1.40 (+0.01)
ProPhase Finalizes Resolution of Long-Standing Litigations
Marketwire - Wed Sep 10, 3:10PM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) announced today the Company has consummated a definitive, global Settlement Agreement ("Settlement Agreement"
resolving all of its litigation with certain of the Company's former managers and with certain shareholders. The cases that have been settled include ProPhase Labs, Inc. v. Quigley, et al., Court of Common Pleas of Bucks County, Pennsylvania, Civ. A. No. 2010-08227; ProPhase Labs, Inc. v. Quigley, et al., Court of Common Pleas of Bucks County, Pennsylvania, Civ. A. No. 2011-09815; the appeal filed by the plaintiff in the matter Quigley v. ProPhase Labs. Inc.'s Officers and Directors, el al, Court of Common Pleas of Philadelphia County, December Term, 2011, No. 111200409; together with certain ancillary litigation. PRPH: 1.40 (+0.01)
ProPhase Labs posts higher net loss of USD3.1m for three months ended 30 June 2014
M2 - Wed Aug 13, 7:52AM CDT
Medical science company ProPhase Labs (NASDAQ
RPH) disclosed on Tuesday its net loss of USD3.1m (USD0.19 per share) for the three months ended 30 June 2014. PRPH: 1.40 (+0.01)
ProPhase Labs Reports Financial Results for the Three and Six Months Ended June 30, 2014
Marketwire - Tue Aug 12, 7:02AM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported its net sales were $1.8 million for the three months ended June 30, 2014 as compared to net sales of $1.9 million for the three months ended June 30, 2013. The Company realized a net loss for the three months ended June 30, 2014, of $3.1 million, or ($0.19) per share, compared to a net loss of $1.7 million, or ($0.11) per share, for the three months ended June 30, 2013.
PRPH: 1.40 (+0.01)
Nasdaq stocks posting largest volume increases
AP - Tue Jun 24, 5:05PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
RIVR: 21.48 (+0.48), PRPH: 1.40 (+0.01), VRTX: 112.72 (-3.96), CENT: 7.90 (-0.06), NURO: 1.67 (+0.06), PLXT: 6.50 (+0.02), PRKR: 1.10 (+0.02), CENTA: 8.59 (-0.04), COCO: 0.16 (unch), MSBF: 8.51 (+0.06), UCBA: 12.04 (+0.04), MCRS: 67.99 (unch), NSPH: 0.43 (-0.01)
4 Stocks Under $10 Moving Higher
at The Street - Fri Mar 28, 5:00AM CDT
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
PRPH: 1.40 (+0.01), BXE: 4.55 (-0.26), FHCO: 4.31 (-0.10), OSUR: 8.96 (-0.22)
ProPhase Labs Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2013
Marketwire - Thu Mar 27, 9:12AM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported a net sales increase of 5.8% to $9.6 million for the three months ended December 31, 2013 as compared to net sales of $9.1 million for the three months ended December 31, 2012.
PRPH: 1.40 (+0.01)
OTC Daily Alert Stock Watch - ProPhase Labs, Inc. (NASDAQ: PRPH)
WorldStockWire - Mon Sep 02, 5:30PM CDT
OTC Daily Alert tracks stocks daily and is pleased to offer features on public companies. Investors can receive FREE Stock Alerts and company news and profiles by visiting OTC Daily Alert at the following: http://www.otcdailyalert.com
PRPH: 1.40 (+0.01)
ProPhase Labs Reports Financial Results for the First Quarter Ended March 31, 2013
Marketwire - Mon May 06, 8:30AM CDT
ProPhase Labs, Inc. (NASDAQ: PRPH) (www.ProPhaseLabs.com) today reported a net sales increase of 25.3% to $7.5 million for the three months ended March 31, 2013 as compared to net sales of $6.0 million for the three months ended March 31, 2012.
PRPH: 1.40 (+0.01)
ProPhase Labs Inc's net loss narrows to USD1.1m in 2012
M2 - Wed Mar 27, 9:15AM CDT
Medical science company ProPhase Labs Inc (NASDAQ
RPH) stated on Tuesday its net loss of USD1.1m (USD0.07 per share) for the year ended 31 December 2012. PRPH: 1.40 (+0.01)
Market Maker Surveillance Report. CBMX, CBB, AMBO, PRPH, XWES, EORBF, Losing Stocks With Lowest Price Friction For Wednesday, February 27th 2013
M2 - Thu Feb 28, 2:49AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3942 companies with "abnormal" market making, 3560 companies with positive Friction Factors and 1802 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Wednesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. CombiMatrix Corp (NASDAQ:CBMX), Cincinnati Bell Inc (NYSE:CBB), Ambow Education Holding Ltd (NYSE:AMBO), Prophase Labs Inc (NASDAQ
RPH), World Energy Solutions Inc (NASDAQ:XWES), (OTC:EORBF). To access Friction Factor, Naked Short Data and SqueezeTrigger Price PRPH: 1.40 (+0.01), XWES: 5.45 (unch), CBMX: 1.37 (-0.07), CBB: 3.41 (-0.03)
Market Maker Surveillance Report. PTSX, NVTL, PRPH, RNIN, MNOV, CWH, Winning Stocks With Lowest Price Friction For Tuesday, February 26th 2013
M2 - Wed Feb 27, 2:38AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 4094 companies with "abnormal" market making, 2796 companies with positive Friction Factors and 2447 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Tuesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Point.360 (NASDAQ
TSX), Novatel Wireless Inc (NASDAQ:NVTL), Prophase Labs Inc (NASDAQ RPH), Wireless Ronin Technologies Inc (NASDAQ:RNIN), MediciNova Inc (NASDAQ:MNOV), CommonWealth REIT (NYSE:CWH). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices PTSX: 0.32 (+0.01), PRPH: 1.40 (+0.01), MNOV: 3.04 (-0.01), CWH: 26.86 (-0.33), NVTL: 2.56 (+0.02)
Matrixx Initiatives Withdraws Acquisition Offer for ProPhase Labs
PR Newswire - Tue Feb 05, 8:00AM CST
Matrixx Initiatives, Inc., the maker of the Zicam® cold, sinus and allergy line of products, announced today that it has withdrawn the $1.60 per share offer it made in October to acquire all of the outstanding shares of ProPhase Labs, Inc. (NASDAQ: PRPH) .
PRPH: 1.40 (+0.01)
